NEW YORK, Feb. 28 /PRNewswire/ -- The New York Biotechnology Association (NYBA), a not-for-profit trade association dedicated to the development and growth of New York State - based biotechnology related industries, announced today that the organization’s 2006 Annual Meeting will take place on April 17-18 in New York City, at the Marriott Marquis Hotel. More than 500 scientists, medical researchers, biotechnology business executives, investors, policy makers and journalists will convene for NYBA’s 16th annual meeting.
NYBA’s two-day annual meeting will feature more than 20 panel discussions including speakers representing many of the association’s prominent members who will examine and discuss issues critical to the ongoing success of the industry from a financial, public policy, research and business development perspective. Sessions will focus on topics impacting the industry in NYS and beyond such as preparing for personalized medicine, trends in venture capital financing, negotiating biotech-pharma collaborations, overcoming international issues, and ensuring FDA compliance.
The meeting will also include two plenary luncheon programs. Cynthia Robbins-Roth, Ph.D, founder of BioVenture Publishing Inc. and BioVenture Consultants, will be the featured speaker on Monday, April 17th with remarks entitled, “Money, Products and Politics: Industry Trends and What They Mean for New York.” On Tuesday, April 18th, the plenary session will be a panel discussion entitled: “Living with Illness: Biotechnology Finding the Cures.” During this session, leading industry experts will discuss how to overcome the challenges of finding medical cures for chronic diseases from the perspective of the patient, disease advocate, researcher and biotech executive.
“We are very proud of this year’s annual meeting program as it is exceptionally strong in content that directly relates to the challenges faced by NYBA’s members and in the caliber of speakers, most of whom are leading scientists, researchers, and business leaders who work in the New York biotech community,” said Karin Duncker, NYBA Executive Director. “NYBA looks forward to a successful meeting that will not only highlight the tremendous biotechnology assets unique to NYS but also that provides insight into how New York’s biotech community can play a key role in developing new products and policy for global health.”
For program and registration information, please visit the NYBA website: http://www.nyba.org.
About NYBA
NYBA is the leading advocate for advancing the success of the biotechnology industry in New York State and is its main representative to policy makers, the media and the communities in which we work. Our mission is to support the development and growth of New York’s biotechnology industry, and serve our members and the biotechnology community by providing a network for information exchange, shared services and collective action. NYBA’s membership comprises over 250 bioscience companies, world-class research institutions and related professional services. Under the banner of The Cures Start Here(R), our goal is to amplify the success New York has had and continues to have in discovering major medical advances and growing a vibrant biotech industry. For more information on NYBA programs and initiatives, visit our website at http://www.nyba.org.
New York Biotechnology Association
CONTACT: Karin Duncker, Executive Director, +1-212-332-4395,kduncker@nyba.org; or Paul Kidwell, Suda Communications, +1-617-296-3854,paulkidwell@comcast.net
Web site: http://www.nyba.org/
